81 related articles for article (PubMed ID: 21420224)
21. Effect of HLA DQ2, dietary exposure and coeliac disease on the development of antibody response to gliadin in children.
Ludvigsson JF; Eylert M; Ilonen J; Ludvigson J; Vaarala O
Scand J Gastroenterol; 2006 Aug; 41(8):919-28. PubMed ID: 16803690
[TBL] [Abstract][Full Text] [Related]
22. Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa.
Salvati VM; Mazzarella G; Gianfrani C; Levings MK; Stefanile R; De Giulio B; Iaquinto G; Giardullo N; Auricchio S; Roncarolo MG; Troncone R
Gut; 2005 Jan; 54(1):46-53. PubMed ID: 15591503
[TBL] [Abstract][Full Text] [Related]
23. Gliadin-dependent cytokine production in a bidimensional cellular model of celiac intestinal mucosa.
Vincentini O; Maialetti F; Gonnelli E; Silano M
Clin Exp Med; 2015 Nov; 15(4):447-54. PubMed ID: 25447031
[TBL] [Abstract][Full Text] [Related]
24. Persistently positive gliadin antibodies without transglutaminase antibodies in the elderly: gluten intolerance beyond coeliac disease.
Ruuskanen A; Luostarinen L; Collin P; Krekelä I; Patrikainen H; Tillonen J; Laurila K; Haimila K; Partanen J; Mäki M; Valve R; Kaukinen K
Dig Liver Dis; 2011 Oct; 43(10):772-8. PubMed ID: 21641886
[TBL] [Abstract][Full Text] [Related]
25. The effects of atorvastatin on gluten-induced intestinal T cell responses in coeliac disease.
Ráki M; Molberg O; Tollefsen S; Lundin KE; Sollid LM
Clin Exp Immunol; 2005 Nov; 142(2):333-40. PubMed ID: 16232221
[TBL] [Abstract][Full Text] [Related]
26. Characterization of IL-17A-producing cells in celiac disease mucosa.
Monteleone I; Sarra M; Del Vecchio Blanco G; Paoluzi OA; Franzè E; Fina D; Fabrizi A; MacDonald TT; Pallone F; Monteleone G
J Immunol; 2010 Feb; 184(4):2211-8. PubMed ID: 20061410
[TBL] [Abstract][Full Text] [Related]
27. Interferon alpha and alcohol augment nuclear regulatory factor-kappaB activation in HepG2 cells, and interferon alpha increases pro-inflammatory cytokine production.
Szabo G; Catalano D; Bellerose G; Mandrekar P
Alcohol Clin Exp Res; 2001 Aug; 25(8):1188-97. PubMed ID: 11505050
[TBL] [Abstract][Full Text] [Related]
28. Enteric glial-derived S100B protein stimulates nitric oxide production in celiac disease.
Esposito G; Cirillo C; Sarnelli G; De Filippis D; D'Armiento FP; Rocco A; Nardone G; Petruzzelli R; Grosso M; Izzo P; Iuvone T; Cuomo R
Gastroenterology; 2007 Sep; 133(3):918-25. PubMed ID: 17678654
[TBL] [Abstract][Full Text] [Related]
29. Unexpected role of surface transglutaminase type II in celiac disease.
Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
[TBL] [Abstract][Full Text] [Related]
30. Barley and rye prolamins induce an mRNA interferon-gamma response in coeliac mucosa.
Bracken SC; Kilmartin C; Wieser H; Jackson J; Feighery C
Aliment Pharmacol Ther; 2006 May; 23(9):1307-14. PubMed ID: 16629935
[TBL] [Abstract][Full Text] [Related]
31. Altered expression of the lymphocyte activation antigen CD30 in active celiac disease.
Periolo N; Guillén L; Bernardo D; Niveloni SI; Hwang HJ; Garrote JA; Bai JC; Arranz E; Cherñavsky AC
Autoimmunity; 2010 Jun; 43(4):288-98. PubMed ID: 20166880
[TBL] [Abstract][Full Text] [Related]
32. Celiac disease pathogenesis: the proinflammatory cytokine network.
Garrote JA; Gómez-González E; Bernardo D; Arranz E; Chirdo F
J Pediatr Gastroenterol Nutr; 2008 Aug; 47 Suppl 1():S27-32. PubMed ID: 18667914
[TBL] [Abstract][Full Text] [Related]
33. In vitro pathogenetic studies of coeliac disease. Effects of protein digests on coeliac intestinal biopsy specimens maintained in culture for 48 hours.
Jos J; Lenoir G; Ritis G D; Rey J
Scand J Gastroenterol; 1975; 10(2):121-8. PubMed ID: 1091964
[TBL] [Abstract][Full Text] [Related]
34. T cell proliferation, MHC class II restriction and cytokine products of gliadin-stimulated peripheral blood mononuclear cells (PBMC).
O'Keeffe J; Mills K; Jackson J; Feighery C
Clin Exp Immunol; 1999 Aug; 117(2):269-76. PubMed ID: 10444257
[TBL] [Abstract][Full Text] [Related]
35. Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modifications of toxic peptide generation during digestion.
Laparra JM; Sanz Y
J Cell Biochem; 2010 Mar; 109(4):801-7. PubMed ID: 20052669
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease.
Benahmed M; Meresse B; Arnulf B; Barbe U; Mention JJ; Verkarre V; Allez M; Cellier C; Hermine O; Cerf-Bensussan N
Gastroenterology; 2007 Mar; 132(3):994-1008. PubMed ID: 17324400
[TBL] [Abstract][Full Text] [Related]
37. Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody.
Przemioslo RT; Lundin KE; Sollid LM; Nelufer J; Ciclitira PJ
Gut; 1995 Jun; 36(6):874-9. PubMed ID: 7615276
[TBL] [Abstract][Full Text] [Related]
38. Avenin fails to induce a Th1 response in coeliac tissue following in vitro culture.
Kilmartin C; Lynch S; Abuzakouk M; Wieser H; Feighery C
Gut; 2003 Jan; 52(1):47-52. PubMed ID: 12477758
[TBL] [Abstract][Full Text] [Related]
39. mTOR sustains inflammatory response in celiac disease.
Sedda S; Dinallo V; Marafini I; Franzè E; Paoluzi OA; Izzo R; Giuffrida P; Di Sabatino A; Corazza GR; Monteleone G
Sci Rep; 2020 Jul; 10(1):10798. PubMed ID: 32612145
[TBL] [Abstract][Full Text] [Related]
40. Vitamin C as a supplementary therapy for celiac disease?
Lindfors K; Kaukinen K
Allergol Immunopathol (Madr); 2012; 40(1):1-2. PubMed ID: 22024540
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
